Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dodecanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | FABP3 | P05413 | 7/20 | 0.62 |
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.53 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL4230929 | 1.00 | CA1 (0.67) | CA1FABP3CES2CES1NFKB1 | |
| Palmitic Acid SCHEMBL8511539 | 1.00 | CA1 (0.67) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL7042513 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL31357301 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL31210069 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL10488816 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Dodecanoate SCHEMBL8140299 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Octanoic Acid SCHEMBL3283210 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL1002937 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 | |
| Stearic Acid SCHEMBL18197505 | 0.96 | FABP3 (0.62) | CA1FABP3CES2CES1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12487224-B2 | Soil analysis compositions and methods | PRECISION PLANTING LLC (US) | 2025-12-02 | — | — | US | claimed |
| US-12352740-B2 | Soil analysis compositions and methods | PRECISION PLANTING LLC (US) | 2025-07-08 | — | — | US | claimed |
| EP-4182660-B1 | SOIL ANALYSIS COMPOSITIONS AND METHODS | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4182669-B1 | SOIL ANALYSIS METHODS | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4182659-B1 | SOIL ANALYSIS METHOD | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2025051022-A1 | TECHNETIUM [99TC] METHYLENE DIPHOSPHONATE ORAL FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 成都云克药业有限责任公司 | 2025-03-13 | — | — | WO | claimed |
| CN-119111517-A | Air response type long-acting stable chlorine dioxide sustained-release tablet | 广西艾科宁消毒科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-20240301326-A1 | CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION | Reckitt Benckiser Health Limited (GB) | 2024-09-12 | — | — | US | claimed |
| CN-118393828-A | Stripping composition of high heat resistance photoresist and application thereof | 上海飞凯材料科技股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-4373906-A1 | CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2024-05-29 | — | — | EP | claimed |
| WO-2015100348-A1 | KELOID REDUCTION USING TOPICAL ALLANTOIN | SCIODERM, INC. (US) | 2015-07-02 | — | — | WO | claimed |
| US-20150133543-A1 | TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2015-05-14 | — | — | US | claimed |
| EP-2858629-A1 | A TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | Leo Laboratories Limited (IE) | 2015-04-15 | — | — | EP | claimed |
| US-20140288137-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | SCIODERM, INC. (US) | 2014-09-25 | — | — | US | claimed |
| US-20140206732-A1 | Compositions and Methods of Treatment of Inflammatory Skin Conditions Using Allantoin | SCIODERM, INC. (US) | 2014-07-24 | — | — | US | claimed |
| US-20140194482-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2014-07-10 | — | — | US | claimed |
| US-20140121255-A1 | Methods of Treating Psoriasis Using Allantoin | SCIODERM, INC. (US) | 2014-05-01 | — | — | US | claimed |
| WO-2013182688-A1 | A TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2013-12-12 | — | — | WO | claimed |
| WO-2008042557-A2 | FORMULATION AND METHOD FOR A SHAMPOO FOR ANIMALS | EPIDERMAPET, LLC (US) | 2008-04-10 | — | — | WO | claimed |
| US-20080081036-A1 | FORMULATION AND METHOD FOR A SHAMPOO FOR ANIMALS | EPIDERMA PET, LLC (US) | 2008-04-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288137-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | CUTA, ITCH, ARG1 | CA1 1533/4885FABP3 1829/4885CES2 1659/4885 |
| US-20140194482-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | CUTA, ITCH, ARG1 | CA1 1533/4885FABP3 1829/4885CES2 1659/4885 |
| US-20140206732-A1 | Compositions and Methods of Treatment of Inflammatory Skin Conditions Using Allantoin | CUTA, ITCH, ARG1 | CA1 1533/4885FABP3 1829/4885CES2 1659/4885 |
| US-20140121255-A1 | Methods of Treating Psoriasis Using Allantoin | CUTA, ITCH, PPIA | CA1 1224/4885FABP3 1690/4885CES2 1440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.